Artificial Intelligence

OpenEvidence

OpenEvidence is an AI-native company in Artificial Intelligence, based in United States. Shown below: 1 tool, 5 funding rounds.

AI-native Not profitable Featured: OpenEvidence US

$12B

Listed valuation

Visit website
Employees
36
Raised
$740M
Valuation / employee
$333.33M
Tools
1
Rounds
5

Figures and classifications reflect imported catalog records, not live company reporting.

Tools

1 in the catalog

In the catalogs

4

Models

  • Darwin Darwin is OpenEvidence's most advanced medical AI model, the first to achieve a perfect score on the MedQA be…
  • Osler Osler is OpenEvidence's fastest medical AI model, delivering answers to clinical queries in about 5 seconds.…
  • Sackett Sackett is an evidence weighing medical AI model from OpenEvidence that uses interactive questioning to analy…
  • Snow Snow is OpenEvidence's deepest production model, conducting a full medical literature investigation over abou…

Funding rounds

5 rounds

  • Series D Announced 21 Jan 2026 · Leads: DST Global, Thrive Capital
    $250M Raised $250M Round $12B Post-money 19 investors Closed
  • Series C Announced 20 Oct 2025 · Leads: Google Ventures
    $200M Raised $200M Round $6B Post-money 8 investors Closed
  • Series B Announced 15 Jul 2025 · Leads: Google Ventures, Kleiner Perkins
    $210M Raised $210M Round $3.50B Post-money 7 investors Closed
  • Series A Announced 19 Feb 2025 · Leads: Sequoia Capital
    $75M Raised $75M Round $1B Post-money 1 investors Closed
  • Seed Announced 01 Nov 2021
    $5M Raised $5M Round 1 investors Closed

Source rankings

Imported positions; not an independent quality score.

  • Overall Rank#181
  • AI Native Rank#53
  • Rank#87